Abiopharma

FTRE Investors Have Opportunity to Lead Fortrea Holdings Inc. Securities Fraud Lawsuit with the Schall Law Firm

Cabaletta Bio Announces Pricing of Public Offering of Securities

Hawkins, Inc. to Participate in CJS Securities 25th Annual New Ideas Summer Conference

Capricor Therapeutics Announces Key Regulatory Updates for its Duchenne Muscular Dystrophy Program

NEOG Investors Have Opportunity to Join Neogen Corporation Fraud Investigation with the Schall Law Firm

Moleculin Participates in Virtual Investor "What This Means" Segment

Inspira’s ART100 in Use at Tier-1 U.S. Hospitals, Generating Strong Clinical Interest and Accelerating Sales Discussions

Fate Therapeutics Announces Updated Clinical Data for FT819 Off-the-shelf CAR T-cell Product Candidate Demonstrating Durability of Drug-free Remission for Severe Lupus Nephritis at EULAR 2025 Congress

Sharps Technology Inc. Notification (STSS)

Hyperfine Announces Key Executive Appointments to Strengthen its Leadership Position in AI-Powered Portable MRI